SCHEMBL23920716

SCHEMBL23920716

CC/C(=C\F)Cn1cc(C(=O)OC)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
GRM2 Q14416 1/20 0.37
ACHE P22303 2/20 0.36
LMNA P02545 3/20 0.34
MAPT P10636 2/20 0.34
CYP2C19 P33261 1/20 0.34
GFER P55789 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PLA2G4A P47712 1/20 0.33
TP53 P04637 2/20 0.33
ABL1 P00519 1/20 0.32
CSF1R P07333 1/20 0.32
LYN P07948 1/20 0.32
TGFBR1 P36897 1/20 0.32
TGFBR2 P37173 1/20 0.32
SIK1 P57059 1/20 0.32
SIK2 Q9H0K1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22206967 0.88 GRM2 (0.38) HPGDKDM4EALDH1A1L3MBTL1GRM2
SCHEMBL22206966 0.88 GRM2 (0.38) HPGDKDM4EALDH1A1L3MBTL1GRM2
SCHEMBL22216432 0.85 KDM4E (0.38) HPGDKDM4EALDH1A1L3MBTL1GRM2
SCHEMBL22216433 0.85 L3MBTL1 (0.56) L3MBTL1ACHELMNAMAPTCYP2C19
SCHEMBL22216435 0.84 L3MBTL1 (0.39) HPGDKDM4EALDH1A1L3MBTL1ACHE
SCHEMBL22216455 0.83 LMNA (0.42) HPGDKDM4EALDH1A1L3MBTL1ACHE
SCHEMBL22216190 0.82 AOC3 (0.42) HPGDKDM4EALDH1A1L3MBTL1ACHE
SCHEMBL22216353 0.80 POLB (0.51) HPGDKDM4EALDH1A1MAPTCYP2C19
SCHEMBL28427420 0.80 HDAC3 (0.33) HPGDKDM4EALDH1A1GRM2ACHE
SCHEMBL28427418 0.80 HDAC3 (0.33) HPGDKDM4EALDH1A1GRM2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3892621-A1 HALOALLYLAMINE COMPOUNDS AND APPLICATION THEREOF Nanjing Transthera Biosciences Co., Ltd. (CN) 2021-10-13 EP disclosed